PKBDO4993MAKL
PKBDO4993MAKL
released
Clinical summary
Diabetes status
Type 2 Diabetes
BMI
34.1
HbA1c %
—
C-Peptide (ng/ml)
5.2
Diabetes duration
1
Demographics
- Age (y)
- 13
- Gender
- Female
- Ethnicity
- White
Additional clinical
- Diabetes (ontology)
- T1D stage
- No sufficient information to derive
- Living donor
- No
- Cause of death
- Other
- Hospital stay (h)
- 72
Autoantibodies
GADANegative
No value
IAANegative
No value
IA2Negative
No value
ZNT8Negative
No value
HLA typing
| Locus | Allele 1 | Allele 2 | Method |
|---|---|---|---|
| A | 01:01 | 24:02 | NGS |
| B | — | — | NGS |
| C | — | — | NGS |
| DRB1 | 03:01 | 03:01 | NGS |
| DQA1 | 05:01 | 05:01 | NGS |
| DQB1 | 02:01 | 02:01 | NGS |
| DPA1 | — | — | NGS |
| DPB1 | — | — | NGS |
Supplementary
nPOD
nPOD_portal:6308
- Pancreas tissue available
- Yes
- Other tissues
- —
Attribution
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
